Английская Википедия:EpiVax
Материал из Онлайн справочника
Шаблон:Short description EpiVax is an American biotechnology company based in Rhode Island.[1] The company was founded in 1998 by Anne Searls De Groot, who serves as its CEO and CSO.[2] EpiVax holds the exclusive license to the EpiMatrix vaccine design technology.[3][2] In 2020 it developed a COVID-19 vaccine, EPV-CoV19, in partnership with the University of Georgia and Immunomic Therapeutics.[4][5][6]
References
External links